Complementary role of mathematical modeling in preclinical glioblastoma: differentiating poor drug delivery from drug insensitivity
J. C. Urcuyo, S. C. Massey, A. Hawkins-Daarud, B.-M. Marin, D. M. Burgenske, J. N. Sarkaria, K. R. Swanson
This paper uses mathematical modeling to differentiate between drug insensitivity and poor drug delivery in glioblastoma PDX models, validated by experimental results.
bioRxiv · Dec 7, 2021 · PreprintCancer Biology